H e m ato l o g y a n d O n c o l o g y
A f o c u s o n P ro s tat e Ca n c e r
2009 annual report
Randy Hurley, M.D.
I am excited to present this year’s HealthPartners and Regions Hospital Hematology and Oncology Annual
Report. We are an American College of Surgeons certified comprehensive community cancer center with an
emphasis on patient care and a strong focus on education and clinical research.
From a patient care standpoint, we leverage the membership in our non-profit integrated health care system
to improve the care we give our patients. We coordinate multidisciplinary cancer care through the use of an
electronic medical record. We empower patients with tools to make informed choices including our online
services, the Lundborg Patient Library and additional programs. We use standardized treatment algorithms
based on national consensus guidelines to ensure all patients, including the underserved, receive the best
treatment available. Finally, we measure outcomes and compare ourselves with national benchmarks to
ensure quality cancer care delivery.
In this issue we highlight our multidisciplinary approach to early-stage prostate cancer. Prostate cancer
is the most common cancer affecting men. The incidence of prostate cancer in men is higher than the
incidence of breast cancer in women. Just as women have choices for the treatment of early-stage breast
cancer, men also have choices for the treatment of early stage prostate cancer. Inside, we describe our
shared decision making program and treatment options for men with early-stage disease.
Lastly, I take pride in “showing off” our new in-patient cancer unit. With the Regions 2009 expansion, we
now have a new state-of-the-art in-patient facility for patients requiring hospitalization for their cancer care
at Regions Hospital.
Once again, we appreciate the privilege of serving you and your patients. Please feel free to contact me if
you have any questions about our program or have suggestions on ways we can improve the care we deliver.
Randy Hurley, M.D.
Medical Director, HealthPartners/Regions Hematology and Cancer Care Program
Assistant Professor of Medicine
Division of Hematology, Oncology and Transplantation
University of Minnesota
2 hematology and oncology
Regions Expansion 2009
This was an exciting year for Regions Hospital. We opened the new
section of the hospital which includes a new main entrance, private
patient rooms, emergency center, 20 operating rooms and
a 450-space underground parking ramp.
As part of our expansion, patients needing inpatient care for their
oncology treatments are now located in our new 6 South Section.
This unit incorporates staff from three existing units into one central Our hematology and oncology patients are
area. Nursing care is given to patients with differing requirements now located in new private patient rooms.
including general medical
2009 Regions Hospital expansion care, intermediate care and intensive care. Physicians who
includes new inpatient oncology unit. direct the care of the patient unit include Regions hospitalists,
intensivists, oncologists and other specialists as needed.
The 6 South Section includes 36 private patient rooms, each
with their own bathroom. The new patient rooms were designed
to accommodate differing care needs including rooms to suit
special needs related to isolation. The patient rooms are large
and include abundant natural light and spectacular views of
downtown St. Paul. Each room has been designed to support our
goal of being a patient/family centered hospital. Each room has a
provider zone, patient zone and family zone. The provider space
allows the caregiver staff, including nurses, closer access to the
patient. Besides family space in the room, there are separate
areas on the unit for private conferences as well as open areas
for waiting. Our new unit brings our whole team together in a
centralized location and allows us to be closer to the patient
Lundborg Library nears 10-year milestone
The Patricia D. Lundborg Cancer Library at Regions Hospital offers cancer resources in a convenient,
on-site facility. The library, created in 2000, is staffed by a librarian and provides resources for patients,
their families and friends, hospital staff and members of the community. Annual library usage has
continued to increase each year. The Library enters its 10th year of existence in 2010.
A continuum of care through palliative care and hospice
HealthPartners Cancer Care Centers partner with HealthPartners Hospice and the Regions Hospital
Palliative Care Team to provide a continuum of care that enhances end of life care. Multidisciplinary
team meetings are held weekly and include representatives from medical oncology, nursing, inpatient
and outpatient social work, health psychology, HealthPartners hospice and palliative care team members.
Through this partnership, care is coordinated from the hospital to the clinic to the patient’s home.
2009 annual report 3
people Program News
Survivorship Program enters second year
is the medical The HealthPartners and Regions Cancer Survivorship Program, under the direction
director of the of Dr. Kurt Demel, is entering its second year of providing comprehensive
survivorship survivorship care plans to cancer patients. The success of the program has led to an
program invitation to participate in the Excellence in Survivorship care meeting. Sponsored
completed his by the Livestrong Survivorship Center of Excellence, this program is designed to
MBA. foster and improve cancer survivorship care.
Cancer Survivors Advisory Council
Morton, MD, The HealthPartners Cancer Survivors Advisory Council is a forum for patients who
hemostasis and have completed their acute cancer treatment at Regions Hospital and Riverside Cancer
thrombosis Care Centers and who are now transitioning into long-term cancer management.
Members of the council are asked to share their experiences and to contribute
disorders of pregnancy and is ideas on how HealthPartners can improve the treatment and support of cancer
working with the U of M to survivors. The twelve-member council met seven times in 2009 and was asked to
develop city-wide protocols make recommendations on services already offered and to assist with the design of
to standardize treatment
of bleeding and clotting new services. The first topic presented to the council was patient education materials.
disorders. Feedback from the council guided the changes we made. Educational materials are
now easier to understand and more specific to the needs of the patient.
The experiences and recommendations of the advisory council were also an integral
part of the development of two new programs that began in late 2009. “Let’s Get
treats adult Physical” is a beginner-level physical activity class tailored to the needs of cancer
patients with patients who want to improve their level of physical conditioning. “Renewing Life”
oncologic and is a transformative program of education and support that engages participants in
diseases and an exploration of the possibilities for growth in living with serious illness. Both of
was named to these programs are lead by cancer survivors and are available at a minimal cost.
the Minnesota Monthly Top
Doctors for Women 2009 list. Our hematology and oncology program utilizes a Cancer Survivors Advisory Council
to help us make recommendations on new and existing patient services.
Back row: Scott Cruse, Marge Watry, Ron Bentley, Carolyn Markwood Nyberg,
Churon Webb, Micky Gutzmann, Gobind Tarchand, Marjorie Moore
Dan Front row: Deanna McWilliam, Joe Kennedy, Judy Clasen
of over 220
physicians in the
4 hematology and oncology
Training tomorrow’s hematologist/oncologists — medical
HealthPartners’ partnership with the University of Minnesota oncology and
Division of Hematology, Oncology and Transplantation with interests
Fellowship program in breast
Regions Hospital is a clinical training site for the University of Minnesota hematologic
Hematology/Oncology Fellowship program and is regarded as one of the highest malignancies. He is also
the Regions site director
ranked rotations by University Fellows. Dr. Jeff Jaffe heads the teaching program for Hematology/Oncology
at Regions Hospital which combines clinical experience with specific teaching educational programs for
conferences. With over 20 years of teaching experience, Dr. Jaffe and other the University of Minnesota
HealthPartners oncologists have mentored many of the oncologists that practice
in the Twin Cities area. This year, three HealthPartners oncologists were nominated
for a teaching award among teaching faculty at the University of Minnesota,
Veterans Administration Hospital and Hennepin County Medical Center. Balkrishna
Dr. Balkrishna Jahagirdar won the award for outstanding clinical mentorship. Jahagirdar,
Regions hematology and oncology faculty provide elective rotations for the the 2009
University of Minnesota internal medicine residents and teach in the Medical School Outstanding
second year hematology course for medical students. Faculty also coordinate six Clinical
hours of hematology and oncology lectures in the University’s Global Health course. award from the University
of Minnesota Hematology
Oncology Fellowship Program.
HealthPartners hosts Oncology Nursing Symposium
In April 2009, HealthPartners hosted an Oncology Nursing Symposium. This half-
day event was certified for continuing education credit by the Oncology Nursing
Society and was attended by over 60 nurses and health care professionals from the Oncology
Twin Cities area and western Wisconsin. A wide range of topics were discussed Social
including oncologic emergencies, survivorship and new trends in cancer clinical Worker,
trials. We look forward to a second symposium in April 2010. in working
Regions Breast Health Center partners with University of the trauma of cancer, facilitating
patient support groups and
Minnesota to develop breast radiology fellowship developing programs and
services for patients.
The Regions Hospital Breast Health Center partnered with the University of
Minnesota, Saint Paul Radiology and four radiology practices in the Twin Cities
to develop a Breast Imaging Fellowship program to train two board certified
radiologists each year in the radiology subspecialty of breast imaging. This unique Joe Tashjian,
MD, is the
program has the advantage of combining the comprehensive research program in coordinator
breast imaging at the University of Minnesota with the excellent clinical practices of the breast
that are present at community centers, including the Regions Hospital Breast Health radiology
Center. The partnership will allow the program to attract highly qualified and program
motivated individuals into the arena of breast imaging and will increase the number and is a
of dedicated breast imagers to serve our community in the future. radiologist with St. Paul
Radiology who specializes in
chest and breast imaging and
2009 annual report 5
Anderson, Minnesota CGOP and Minnesota CCOP to merge
is the Dr. Dan Anderson of HealthPartners and Regions Hospital is the director of the
Minnesota Cooperative Group Outreach Program (CGOP). The CGOP provides
and director access to over 80 National Cancer Institute-sponsored clinical trials for patients
for the with cancer. HealthPartners provides the largest number of additions to clinical
Minnesota Cooperative Group trials in this program. Plans are underway to merge CGOP with the Minnesota
Community Cancer Oncology Program (CCOP) and develop an even larger
consortium with expanded access to clinical trials.
Rolnick, Cancer Research Network celebrates 10th year
MPH, is the Ten years ago, HealthPartners Research Foundation (HPRF) became a
associate participating organization of the Cancer Research Network (CRN). The CRN is a
research for consortium of 14 non-profit research centers that collectively provide care to over
the HPRF 11 million individuals across the United States. Through the CRN connection,
and a member of the Cancer HealthPartners has also been involved with the Minnesota Cancer Alliance
Research Network. She will
(MCA), a consortium developed to implement Minnesota’s Comprehensive
take over as the Chair of the
Minnesota Cancer Alliance Cancer Control Plan.
Steering committee in 2010.
Colorectal cancer Survivor Care Plan in development
Kathy HealthPartners Research Foundation, in collaboration with the Minnesota Cancer
Fuhrmann, Alliance, has received a grant from the American Cancer Society to develop a
MS, Certified Survivorship Care Plan specifically for colorectal cancer. This two-year research
Counselor, project will involve obtaining input from health care providers and survivors across
provides Minnesota on elements they would like to see incorporated into a care plan.
services for the Cancer Care
Center for individuals with Pilot project examines text messaging to promote healthy
a personal history of cancer behaviors among adolescent cancer survivors
or a strong family history
of cancers. Dr. Emily Parker, a researcher at HealthPartners Research Foundation, is
conducting a pilot study using text messaging to test weight gain prevention in
adolescent survivors of childhood cancers. Due to late effects of treatment and
disease, survivors of childhood cancers are at increased risk of unhealthy weight
gain, obesity and cardiometabolic disease. Innovative methods of intervention are
needed to address the increased risk of obesity in young cancer survivors.
Data collection on breast cancer in older women continues
Feifei Wei, PhD, is the HealthPartners principal investigator on a continuation
study of long-term (5-year) survivors of breast cancer of those 65 and older. The
study aims to understand and reduce the adverse effects of cancer treatment in
older adults. Additional information will be collected about this breast cancer
cohort through monitoring that will continue for 15 years following treatment.
6 hematology and oncology
A Focus on Prostate Cancer people
Focus on prostate cancer Eberwein,
MD, is the
Prostate cancer is the most common cancer among American men. Nearly one in Chair of
six men will develop prostate cancer in their lifetime. The incidence is highest and Director
in African American men and lowest in Asians and Native Americans. In 2009, of Robotic
192,000 new cases of prostate cancer will be diagnosed. With the advent of the Surgery for
prostate specific antigen (PSA) blood test, more and more men are being diagnosed Hospital and HealthPartners.
at an earlier stage when cancer is still localized to the prostate gland. His interests are minimally
invasive surgical techniques,
endourology and cryotherapy
treatment of urologic
HealthPartners and Regions Hospital prostate malignancies.
HealthPartners and Regions Hospital treated 92 new cases of prostate cancer in Mark
2008 compared to just 39 cases in 2003. This increase is in no small part due to Bisignani,
the development of a dedicated multidisciplinary prostate cancer team. Ninety MD, is the
percent of the cancers in 2008 were diagnosed at an early stage of disease. To director of
facilitate multidisciplinary treatment planning for patients with urologic cancers, the Regions
we participate in specialized Urologic Tumor Conferences and Family Tumor Radiation
Program and has expertise
with intensity modulated
The Surveillance, Epidemiology and End Result (SEER) Program of the National and image guided radiation
Cancer Institute reports 5-year relative survival rates for prostate cancers diagnosed therapy.
between 1999 and 2005. Relative survival rates compare survival of cancer patients
with those of the general population to estimate the effect of cancer. The SEER
database reports a relative survival rate of 100 percent for localized (stage 1 and Cesar
2) and regional (stage 3) prostate cancer and a 30 percent 5-year relative survival
rate for advanced stage 4 disease. The Regions Hospital Cancer Registry reports interest in
overall survival rates which includes death due to unrelated causes. Therefore, it urologic
is not directly comparable to SEER data. The Regions Hospital Cancer Registry oncology,
data reports an 84 percent 5-year overall survival rate for localized disease, a 100 disease and
percent 5-year survival rate for regional stage 3 disease and a 20 percent 5-year general urology.
overall survival rate for advanced stage 4 disease. The Regions prostate cancer
5-year survival (2003-2008) can also be compared to American Joint Committee
on Cancer (AJCC) staging using National Cancer Data Base (NCDB) statistics.
Because of methodology, none of the Regions cases are stage 1. However, the
5-year survival for stage 2, 3 and 4 prostate cancers at Regions Hospital is 85,
100 and 36 percent. This compares to the NCDB 5-year survival of 88, 89 and
37 percent for stage 2, 3 and 4 prostate cancers respectively.
Diana Christensen Johnston
Prostate cancer is the most common cancer and Carol Jirik are
Oncology Certified Nurses
among American men. Nearly one in six men that supervise the Regions
and Riverside Cancer Care
will develop prostate cancer in their lifetime. Centers. Together they have
over 50 years of oncology
2009 annual report 7
A Focus on Prostate Cancer
Multidisciplinary planning and shared decision in the
treatment of early-stage prostate cancer
Early-stage prostate cancer is localized prostate cancer that has not spread beyond
the prostate. Men with newly diagnosed early-stage prostate cancer often have
several treatment options available to them. This may include surgery, radiation
therapy, watchful waiting, and in some instances, cryosurgery. Multidisciplinary
treatment planning involves a team of specialists including a urologic surgeon,
radiation oncologist, and occasionally a medical oncologist. We offer patients and
their families a shared decision-making experience allowing patients to participate
fully in decisions regarding their care.
Treatment options for localized prostate cancer
Robotic Prostatectomy at Regions Hospital
Robotic-assisted laparoscopic prostatectomy is a form
of minimally invasive prostate surgery performed by
Dr. Parker Eberwein and Dr. Cesar Ercole. Robotic
prostatectomy may be a treatment option for patients
with localized prostate cancer. Compared to a traditional
open radical retropubic prostatectomy, advantages* for
patients include a faster recovery time, shorter hospital
stay, and potentially reduced bleeding and less urinary and
Cryosurgery for the treatment of localized
Cryosurgery is the use of extremely cold temperatures
to freeze prostate tumors and kill cancer cells. During an
outpatient procedure, several small needle-like cryoprobes
are inserted into the prostate gland under ultrasound
guidance. Argon gas is then circulated through these probes
during controlled freezing of the prostate gland.
Short term PSA-relapse-free survival is comparable to da Vinci Surgical
radiation therapy with acceptable health-related quality System robot
of life-based outcomes. The American Urological
Association’s 2008 Best Practices Policy Statement on
prostate cryosurgery indicates that in selected patients,
prostate cryosurgery may be an option for the treatment of early stage disease.
Cryosurgery has also been used effectively to treat recurrent prostate cancer after
*As with any surgical procedure these benefits cannot be guaranteed as surgery is both patient-specific and procedure specific.
8 hematology and oncology
A Focus on Prostate Cancer
Regions Hospital has been designated as an International Center
of Excellence for Cryotherapy. Treatment efforts are being led
by Dr. Parker Eberwein who has over a decade of experience
with this technique.
Intensity-Modulated Radiation Therapy
Radiation therapy (RT) and radical prostatectomy are treatment
options with the longest follow-up for patients with localized
prostate cancer. Long-term outcomes are similar.
The goal of RT for men with localized prostate cancer is the
delivery of a therapeutic dose of radiation to the prostate gland Cryosurgery
while minimizing the dose to normal surrounding tissues. The treatment device
prostate gland lies in close proximity to the rectum and bladder.
Avoidance of these structures decreases the risk of long-term
side effects. In recent years, new conformal techniques have been developed which allow
the delivery of higher doses to the prostate and better spare surrounding tissues. Intensity
modulated radiation therapy (IMRT) is a technique which enables the radiation dose to be
‘sculpted’ around the prostate gland. Gold seed markers are usually placed in the prostate gland
prior to a course of radiation therapy. This is helpful in localizing the gland (image-guided
radiation therapy) since the prostate can shift a small degree from day to day. In general,
treatment is very well tolerated. There can be a few minor urinary symptoms such as urgency or
frequency during radiation. Treatments typically take 15-20 minutes each day over an eight and
a half week period of time. Following radiation therapy, response is monitored by observing the
(PSA) level, which is a simple blood test.
Both intensity-modulated and image-guided radiation therapy are available at the Regions
Radiation Therapy Center.
Radiation therapy is an option for prostate
2009 annual report 9
Ca n c e r R e g i s t ry 2 0 0 8
Since 1984, our Cancer Registry has
accumulated over 17,000 cancer cases
and is actively following more than
The main goal of the Cancer Registry is to serve as a
primary source of cancer information for cancer care
professionals. The Cancer Registry contains a wealth of
valuable data, including demographics, histology and
staging, treatment modalities and clinical outcomes. Our
registrars also spend time on follow-up of these cases,
resulting in a 93 percent follow-up rate.
The Registry is also responsible for scheduling weekly
cancer conferences. A significant number of our cancer
patients have their diagnosis and treatment discussed weekly
by a multidisciplinary group of cancer care professionals.
The American College of Surgeons requires that managing
physicians be responsible for documenting accurate staging
of cancer. Our Cancer Registry has a 98 percent accuracy
rate for cancer staging.
Sue Braaten and Margo Hess
To request registry data, please contact our registry Regions Hospital cancer registrars
team at: 651-254-2821
Regions Hospital Cancer Registry 2008
Total Cases in the Cancer Registry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,081
(Since January 1, 1984.)
Total Actively Followed Cases in the Cancer Registry in 2008 . . . . . . . . . . . . . . 5,708
New Cases in 2008
New Analytic Cases in 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,103
(Cases initially diagnosed and/or treated at Regions Hospital.)
New Non-analytic Cases in 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
(Cases that receive subsequent treatment/care at Regions Hospital
following initial diagnosis and treatment at another facility.)
Total New Cases in 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,160
10 hematology and oncology
Cancer Diagnosis and Care
Trends in cancer diagnosis at Regions Hospital
A review of the five-year trends shows an increase in the number of prostate cancer cases. This likely
reflects an increased role of Regions as a referral center and the increased use of our multidisciplinary
prostate cancer approach.
BREAST LUNG COLORECTAL (excluding IN II)*
PROSTATE HEAD & NECK MELANOMA
90 93 92
48 50 49
39 37 38 38
36 35 36
30 31 33
26 28 28
04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08 04 05 06 07 08
Major Cancer Sites — 2008, Regions Hospital
SITE PERCENT SITE PERCENT
Lung 19% Breast 43%
Leukemia/Lymphoma 17% Lung 15%
All others 16% Leukemia/Lymphoma 10%
Prostate 9% All others 9%
Urinary 9% Colorectal 6%
Colorectal 8% Brain 4%
Melanoma 7% Urinary 4%
Head and Neck 6% Melanoma 3%
Brain 3% Gynecologic (excluding CIN III)* 2%
Pancreas 3% Head and Neck 2%
Breast 2% Pancreas 1%
Stomach/Small Bowel 1% Stomach/Small Bowel 1%
*Excluding cervical intraepithelial neoplasia (CIN) III, and benign and borderline malignancies
2009 annual report 11
P ro f e s s i o n a l a n d C o m m u n i t y I n vo lv e m e n t
Professional Organizations & Certifications
Alpha Omega Alpha
American Association of Medical Dosimetrists
American Association of Physicists in Medicine: AAPM - local chapter president
American Association of Physicists in Medicine: faculty member and presenter
American Association of Physicists in Medicine: local chapter secretary
American College of Surgeons
American Freestanding Radiation Oncology Centers
American Medical Association
American Registry of Radiologic Technologists
American Society of Clinical Oncology
THIS PORTION CUT OFF
American Society of Hematology
American Society of Radiologic Technologists
American Society of Therapeutic Radiology and Oncology
American society of Tropical Medicine and Hygiene
Association of Community Cancer Centers
Minnesota Cancer Alliance
Minnesota Society of Clinical Oncology
Oncology Nursing Society
Society for Surgery of the Alimentary Tract
State Advisory Board for Radiation and Radioactive Material
Wilderness Medical Society
Local Community Service
Big Brother Big Sister Volunteer Firefighter
The Breast Cancer 3-Day event Local Women’s Shelter Volunteers,
Twin Cities Marathon including President of the Board
Habitat for Humanity American Red Cross
Animal Humane Society People and Experience Ambassador
League of Women Voters MS/150 Bike Ride
Classroom and Youth Groups Volunteers Relay for Life Participants and Volunteers
Girl and Boy Scouts Al-a Non
Sunday School Teachers Hearing Loss Association of America
Local Food Shelves
Greta Anderson, unit support secretary, completed Cheryl Moulton, RN, participated in the Breast
the Breast Cancer 3-Day event Cancer 3-Day with her daughter
RNs Wendy Ness, Heidi Madison, Mary Srb Stacey Schuette and Donnie Price, RN,
and Kathy Heitzinger attended 2-day oncology Race for the Cure participants
conference at Mayo Clinic Leigh Strassman, Breast Cancer 3-Day volunteer
Kari Richter, RN, completed the Relay for Life of Jessica Appert, Big Brothers and Sisters and
White Bear Lake United Way volunteer
Heather Peterson, RN, completed and was team Mark Towsley, Boy Scout leader and MN
captain for Relay for Life of Woodbury Department of Health Advisory Committee
C81 staff supported cancer survivor and her member
children with holiday giving Regions Cancer Care Center staff supported a
Sheryl Bendickson, RN, was mission chair for the patient and her children with holiday giving
White Bear Lake area American Cancer Society
and captain of We Care Walkers for the Relay for
Life for White Bear Lake
2009 annual report
Tan, WW, Hillman DW, Salim M, Northfelt DW, Anderson DM, Stella PJ, Niedringhaus R, Bernath AM,
Gamini SS, Palmieri F, Perez EA. (2009). Phase 2 trial of weekly irinotecan hydrochloride and docetaxel
in refractory metastatic breast cancer: a north central cancer treatment group (ncctg) trial. Breast Cancer
Res Treat, 106(1), 71-72.
Glasser L, Meloni-Ehrig A, Greaves W, Demel KC, Butera J. (2009). Synchronous development of acute
myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case
with comments on donor evaluation. Transfusion, 49(3), 555-562.
Hussein K, Jahagirdar B, Gupta P, Burns L, Larsen K, Weisdorf D. (2008). Day 14 bone marrow biopsy
in predicting complete remission and survival in acute myeloid leukemia. Am J Hematol, 83(6), 446-50.
Tuttle, TM Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA. (2009).
Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
J Clin Oncol, 27(9), 1362-1367.
Williams B, Morton C. (2008). Cerebral vascular accident in a patient with reactive thrombocytosis: a
rare cause of stroke. Am J Med Sci. 336(3), 279-81.
Coleman LA, Kottke TE, Rank B, Reding DJ, Selna M, Isham GJ, Nelson AF, Greenlee RT. (2008).
Partnering care delivery and research to optimize health. Clin Med Res, 6(3-4), 113-118.
Rank B. (2008). Executive physicals — bad medicine on three counts. N Engl J Med. 359(14), 1424-5.
Jackson, J, Rolnick SJ. (2009). Knowledge, attitudes and preferences regarding advance directives
among patients of a managed care organization. Am J Man Care, 15(3), 177-186.
THIS PORTION CUT OFF
McClure, JB, Divine G, Alexander G, Tolsma D, Rolnick SJ, Stopponi M, et al. (2009). A Comparison
of smokers’ and nonsmokers’ fruit and vegetable intake and relevant psychosocial factors. Behav Med,
Altschuler A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, Herrinton LJ, Harris EL,
Fletcher SW, Emmons KM, Geiger AM. (2008). Positive, negative, and disparate: women’s differing
long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 14(1),
Altschuler, A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, Herrinton LJ, Harris EL,
Fletcher SW, Emmons KM, Geiger AM. (2009). Positive, negative, and disparate--women’s differing
long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J, 14(1),
Rolnick SJ, Jackson JM, Amundson JH. (2009). Development, Implementation and Evaluation of an
Electronic Medical Record Prompt for Bone Density Testing. Health Informatics Journal, [At press].
Stopponi, MA, Ritzwoller DP, Alexander GL, Carroll NM, McClure JB, Divine GW, Calvi JH, Rolnick
SJ, Johnson CC. (2009). Recruitment to a web-based nutritional intervention trial. J Med Internet
Research, 11, 1-11.
Rolnick, SJ, Calvi J, Heimendinger J, McClure JB, Kelley M, Johnson CC, Alexander GL. (2009).
Focus groups inform a web-based program to increase fruit and vegetable intake. Pat Ed and Couns,
Sukhanova A, Ritzwoller DP, Rolnick SJ, Calvi JH, McClure J, Alexander G, Johnson CC. (2009). Focus
groups inform a web-based program to increase fruit and vegetable intake. Patient Educ Couns, 77(2),
hematology and oncology
H e m ato l o g y a n d O n c o l o g y
A f o c u s o n P ro s tat e Ca n c e r
2009 annual report
Hematologists/Oncologists Multidisciplinary Team
Dan Anderson, MD Specialized Surgical Oncologists Pharmacists
Kurt Demel, MD Radiation Oncologists and Certified Medical Assistants
Randy Hurley, MD Therapists Home Care & Hospice
Gretchen Ibele, MD Oncology Certified Nurses Caregivers
Jeffrry Jaffe, MD Clinical Laboratory Technicians Dietitians
Bal Jahagirdar, MD Pathologists Chaplains
Colleen Morton, MD Pain Management Providers Cancer Registrars
Brian Rank, MD Genetics Counselor Ambulatory Coordinators
Daniel Schneider, MD Social Workers Medical Office Assistants
Physician Hotline Multidisciplinary Team Online
651-254-3505 952-967-7616 regionshospital.com/cancer
(for physician questions/consultations only) healthpartners.com/cancer
640 Jackson Street 2220 Riverside Avenue South
St. Paul, MN 55101 Minneapolis, MN 55454